What is Exomind rTMS?
Exomind rTMS (Transcranial Magnetic Stimulation ) represents a groundbreaking, non-invasive treatment tailored for individuals grappling with Major Depressive Disorder (MDD). This innovative therapy employs magnetic fields to stimulate specific nerve cells in the brain, effectively promoting the release of neurotransmitters essential for mood regulation. While Exomind rTMS primarily targets the alleviation of depressive symptoms, it has also demonstrated potential in assisting individuals dealing with anxiety and PTSD. Supported by a robust foundation of scientific research, Exomind rTMS emerges as a vital therapeutic option for patients who have not achieved relief through conventional treatments, such as medication or psychotherapy.
What Does Exomind rTMS Do?
- Targeted Treatment: Exomind rTMS precisely targets areas of the brain that play a crucial role in mood regulation, particularly the prefrontal cortex. By delivering focused magnetic pulses to these regions, the therapy fosters neuroplasticity—the brain’s remarkable ability to adapt and rewire itself. This process leads to enduring improvements in mood, emotional stability, and overall psychological well-being.
- Non-Invasive Procedure: Unlike traditional treatment methods that may involve invasive procedures or anesthesia, Exomind rTMS is entirely non-invasive. Patients typically experience minimal discomfort during the sessions and can seamlessly resume their daily activities immediately afterward. This convenience makes Exomind rTMS an attractive option for individuals seeking effective mental health treatment without significant disruption to their routines.
- Proven Results: Clinical studies consistently demonstrate that Exomind rTMS can significantly reduce symptoms of Major Depressive Disorder. Many patients report marked improvements in mood and overall quality of life after undergoing treatment. Research indicates that rTMS is particularly beneficial for individuals who have not responded well to other therapies, offering renewed hope and a pathway to recovery.
- Personalized Care: At Ascend, we recognize that each patient’s journey is unique. Our team of experienced professionals conducts comprehensive assessments to tailor treatment plans according to individual needs. This personalized approach not only ensures optimal outcomes but also cultivates a supportive environment conducive to healing.
Mental Wellness vs. Mental Illness
Understanding the distinction between mental wellness and mental illness is crucial in addressing the needs of those affected and providing appropriate treatment options:
- Mental Wellness: This term encompasses a holistic state of well-being, where individuals can effectively cope with life’s stresses, develop positive relationships, and maintain a sense of purpose and fulfillment. Mental wellness is characterized by resilience, emotional stability, and the ability to navigate life’s challenges with confidence and grace.
- Mental Illness: In contrast, mental illness includes a spectrum of disorders that disrupt normal functioning, such as Major Depressive Disorder, anxiety disorders, and PTSD. These conditions can lead to significant distress and impair individuals’ ability to perform daily activities or engage in meaningful relationships. Recognizing the signs of mental illness is essential for timely intervention and support.
Exomind rTMS is FDA-approved specifically for the treatment of Major Depressive Disorder, reflecting its efficacy and safety in addressing this serious mental health condition. This endorsement by the FDA underscores the scientific validation of Exomind rTMS as a reliable treatment option, ensuring patients receive a therapeutic approach grounded in rigorous research and clinical evidence. While primarily indicated for depression, the positive outcomes associated with Exomind rTMS can extend to enhancing overall mental wellness, fostering emotional resilience, improving stress management, and elevating overall quality of life.
Pricing
- rTMS single session: $500
- rTMS 6 Session Package: $500 per session
Total: $3000
At Ascend, we are dedicated to making mental health care accessible and affordable. We offer flexible payment plans to accommodate various budgets and financial situations. (Link to the financing options tab on Website)
Additionally, many insurance providers may cover part of the treatment cost, we encourage you to consult with your insurance for specific details regarding your coverage and your Ascend provider.
Empowering Minds, Transforming Lives: Hope and Healing through Exomind rTMS at Ascend Wellness MBS.
Summary of Effectiveness
The effectiveness of Exomind rTMS is further reinforced by compelling clinical trial statistics:
1. Binge Eating Scale (BES) Results:
– After the last treatment, 84% of participants (32 out of 38 subjects) demonstrated a decrease in their BES scores, with an average reduction of 9.8 points (37.8% decrease).
– At the 1-month follow-up, 95% of participants (36 out of 38 subjects) continued to show a reduction in BES scores, with an average decrease of 12.4 points (47.9% decrease).
2. Weight Reduction:
– Following the last treatment, 84% (32 out of 38 subjects) reported weight loss, averaging a reduction of 3.3 lbs (p = 0.0001).
– At the 1-month follow-up, an impressive 95% (36 out of 38 subjects) experienced further weight loss, averaging 4.2 lbs (p < 0.0001).
3. Food Cravings Questionnaire-Trait (FCQ-T):
– After the last treatment, 96% of subjects experienced a reduction in their FCQ-T scores, with an average improvement of 23.1%.
– At the 1-month follow-up, 100% of participants showed a reduction in FCQ-T scores, with an average improvement of 35.9%.
4. Warwick-Edinburgh Mental Well-being Scale (WEMWBS):
– After the last treatment, 83.9% of subjects improved their WEMWBS scores, with an average increase of 7.2 points.
– At the 1-month follow-up, 90.3% of subjects exhibited improvement, with an average increase of 8.5 points.
In conclusion, Exomind rTMS harnesses the power of rTMS to enhance brain function and bolster patients’ psychological resilience. This leads to significant reductions in depressive and anxiety symptoms, improved control over eating behaviors, and overall enhanced mental health outcomes. The accompanying clinical trial statistics provide compelling evidence of its efficacy in addressing MDD, anxiety, PTSD, and BED, while also promoting weight loss and improving overall mental well-being. With a commitment to personalized care and proven results, Exomind rTMS presents a transformative opportunity for those seeking effective mental health treatment.
